The Association between Yang-Deficient Constitution and Clinical Outcome of Highly Active Antiretroviral Therapy on People Living with HIV

Table 4

Characteristics of 142 HIV patients.

Category	Frequency/median
Gender
Male	96
Female	46
Age	35
Yang-Deficient Constitution score	25
HIV disease staging
A	57
B	16
C	69
Mortality	5
CD4 count
Baseline	113
3 months after HAART	202
6 months after HAART	206
9 months after HAART	229
12 months after HAART	269
CD8 count
Baseline	678.5
3 months after HAART	837
6 months after HAART	836
9 months after HAART	861
12 months after HAART	934
Highly active antiretroviral therapy
3TC	142
AZT	45
D4T	95
EFV	71
NVP	62
KALETRA	7
TDF	1
Infection status before starting HAART
Presence of infection before starting HAART	50
Hepatitis B	16
Hepatitis C	19
Pulmonary tuberculosis	30
Extrapulmonary tuberculosis	12
Pneumonia	42
Superficial fungal infections	37
Visceral fungal infections	31
Intestinal infections	10
Encephalitis and meningitis	5
Sexually transmitted disease	2
Newly acquired infection after HAART
Presence of newly acquired infection after HAART	29
Pulmonary tuberculosis	1
Extrapulmonary tuberculosis	6
Pneumonia	7
Superficial fungal infections	2
Visceral fungal infections	6
Intestinal infections	8
Encephalitis and meningitis	2
Other infections	5
Immune reconstitution inflammatory syndrome (IRIS)	9
Adverse events
Fatigue	18
Allergy	50
Alopecia	1
Gastrointestinal reaction	44
Mouth epithelium ulcer and pharyngitis	7
Cerebral symptom	26
Arthralgia	3
Diabetes	1
Hematologic toxicity	48
Hepatotoxicity	49
Abnormal lipid metabolism	26
Pancreatitis	0
Nephrotoxicity	11
Sensory nerve dysfunction	17
Hyperlactacidemia	18
Total number of side effects	24
Number of days an infection occurred after HAART initiation	80